Angeion Corporation (NASDAQ: ANGN) announced today that it has completed its stock repurchase program, purchasing a total of 466,049 shares, at a total cost of approximately $2.0 million. Angeion announced in September 2010 that its Board of Directors had authorized the repurchase of up to $2 million worth of its outstanding shares of common stock in the open market or in privately negotiated transactions under a program set to run until April 30, 2011. Angeion’s Board of Directors approved an increase in the dollar amount authorized under the stock repurchase program to accommodate a final block repurchase.
After completion of the stock repurchase program, Angeion has 3,747,454 shares outstanding.
About Angeion Corporation
Founded in 1986, Angeion Corporation acquired Medical Graphics Corporation in December 1999. Medical Graphics develops, manufactures and markets non-invasive cardiorespiratory diagnostic systems that are sold under the MedGraphics (
) and New Leaf (
) brand and trade names. These cardiorespiratory diagnostic systems have a wide range of applications in healthcare as well as health and fitness. The Company’s products are sold internationally through distributors and in the United States through a direct sales force that targets heart and lung specialists located in hospitals, university-based medical centers, medical clinics and physicians’ offices, pharmaceutical companies, medical device manufacturers, clinical research organizations, health and fitness clubs, personal training studios, and other exercise facilities. For more information about Angeion, visit